Iambic Therapeutics

IAM
13.10011.73% ( -1.740 )
Closed: Nov 13, 16:00:00 (EDT)

Shareholders

All Shareholders

Shareholder Type

  • VC/PE firms27.18%
  • Public and others22.13%
  • Public companies20.28%
  • Hedge funds19.93%
  • Others10.48%

Major Shareholders

Major Shareholders Latest
Shareholder
NVIDIA Corporation
20.28%9.61M--+9.61M
Coatue Management, L.L.C.
19.93%9.45M--+9.45M
Catalio Capital Management, LP
8.85%4.20M--+4.20M
Nexus Venture Partners
6.83%3.24M65.29%-13.79M
Qatar Holding LLC
5.92%2.80M35.67%-7.01M
Ascenta Capital Management Co., L.P.
5.58%2.65M--+2.65M
Frederick ManbyCo-Founder, CTO & Director
3.65%1.73M34.90%-7.37M
ARK Investment Management LLC
3.05%1.44M--+1.44M
Thomas MillerCo-Founder, CEO, Secretary & Director
2.70%1.28M25.79%-5.45M
Michael SecoraChief Corporate Development Officer & CFO
0.53%251.50K5.07%-1.07M
William RastetterIndependent Chairperson
0.42%200.92K--+200.92K
Neil JosephsonChief Medical Officer
0.09%40.46K--+40.46K
Peter OlsonChief Scientific Officer
0.02%11.41K0.02%+11.41K
Tidal Investments LLC
0.02%10.91K--+10.91K
Mary TagliaferriIndependent Director
0.00%0.000.00%+0